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Enhanced cellular uptake of 
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Specific size, shape and surface chemistry influence the biological activity of nanoparticles. In the 
case of lipophilic nanoparticles, which are widely used in consumer products, there is evidence that 
particle size and formulation influences skin permeability and that lipophilic particles smaller than 
6 nm can embed in lipid bilayers. Since most nanoparticle synthetic procedures result in mixtures of 
different particles, post-synthetic purification promises to provide insights into nanostructure-function 
relationships. Here we used size-selective precipitation to separate lipophilic allyl-benzyl-capped silicon 
nanoparticles into monodisperse fractions within the range of 1 nm to 5 nm. We measured liposomal 
encapsulation and cellular uptake of the monodisperse particles and found them to have generally low 
cytotoxicities in Hela cells. However, specific fractions showed reproducibly higher cytotoxicity than 
other fractions as well as the unseparated ensemble. Measurements indicate that the cytotoxicity 
mechanism involves oxidative stress and the differential cytotoxicity is due to enhanced cellular 
uptake by specific fractions. The results indicate that specific particles, with enhanced suitability for 
incorporation into lipophilic regions of liposomes and subsequent in vitro delivery to cells, are enriched 
in certain fractions.
There are an enormous number of possible nanoparticles resulting from combinations of composition, size, shape, 
surface and defects, and cell specific biocompatibility has been found to depend on these nanoparticle parameters1–5. 
Most synthetic methods for producing nanoparticles, however, result in products that are hydrophobic6,7  
in addition to having considerable polydispersity2,8. The polydispersity results in an inhomogeneous broadening 
of the spectral features, thereby producing averaging effects in biomedical imaging applications and cytotoxicity 
studies2,8. Monodisperse samples are hence necessary to narrow the optical, electrical, and biological proper-
ties. Various methods exist for the post-synthetic purification and size-separation of nanoparticles, including 
size-selective precipitation9,10, filtration, size exclusion chromatography11,12, and very recently, density gradient 
ultracentrifugation, all of which allow for the isolation of relatively monodisperse fractions of ligand-passivated 
silicon nanocrystals (ncSi)2,13,14.
While the chemical and physical properties show variation with nanoparticle size, there is also growing evi-
dence that nanoparticle internalization and biological activity depends on specific sizes1,4,15–17. For instance, water 
soluble gold and silica nanoparticles have shown size-dependent cytotoxicity, some over narrow size ranges of less 
than a nanometer, even though bulk gold and silica are known to be biologically inert1,16. The major mechanisms 
by which nanoparticles are known to exert their toxicity on cells include (1) the generation of reactive oxygen 
species (ROS)18,19, (2) alteration of antioxidant enzyme activities, (3) disruption of mitochondrial function, (4) 
oxidative damage in DNA and subsequent disruption of DNA replication and transcription, and (5) disruption 
cellular membrane function, interfering with cellular integrity4,20–27.
In the case of lipophilic nanoparticles delivered by lipid vectors, there is evidence that particle size, compo-
sition and method of formulation influence the encapsulation of the nanoparticles into liposomes and micelles, 
thereby affecting delivery efficiency28–30. Lipophilic nanoparticles’ use in consumer products and potential 
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applications by the therapeutics industry have created a demand for understanding of their interaction with the 
lipophilic regions of liposomes, micelles and living cells, for applications such as enhanced delivery of therapeutic 
agents15,31–33, while also providing a model for nanoparticle interaction with biological membranes34–37.
Traditional methods of encapsulation of hydrophobic nanoparticles include hydration of dry film mixtures 
of phospholipids and nanoparticles, or the use of buffered detergent dialysis of the nanoparticles into the already 
formed liposome. Both methods result in the nanoparticles either being embedded in the hydrophobic bilayer 
region of the liposome or being coated by a lipid bilayer to form a micelle29,30. Previous work has postulated and 
demonstrated a limit of about 6 nm on the size of the nanoparticles encapsulated, but recently larger aggregates 
of multiple nanoparticles about 60 nm in size have been incorporated into liposomes by pre-incorporation clus-
tering of the nanoparticles29,30,38–41.
Semiconductor nanoparticles present promising uses for light-emitting applications14,42–44. These semicon-
ductor nanoparticles are generally composed of a core/shell with the core usually from groups II-VI or III-V2. 
These heavy metals, however, can be toxic even at low concentrations when the cores are exposed to the intra-
cellular environment5,45–47. Silicon represents a potentially non-toxic alternative due to the biocompatibility of 
bulk silicon, the optical properties of nanocrystalline silicon in the visible and near infrared spectrum, and the 
amenability of silicon’s porous form to loading with therapeutic agents2,8,48,49. In this study, we synthesize and 
size-separate allylbenzyl-capped silicon nanocrystals (ncSi:AB), as well as test the fraction-dependent encapsula-
tion efficiency into liposomes and the accompanying cytotoxic effect they exert on HeLa cells.
Results and Discussion
In order to test the fraction-dependent toxicity of the ncSi:AB particles we first needed to size-separate the poly-
disperse mixture into monodisperse fractions and characterize them. Four batches of ncSi:AB fractions were 
used; batches A, B and C each containing 18 monodisperse and a polydisperse ensemble (ENS) fraction were 
used for the toxicity studies, while batch D, which contained 10 monodisperse and an ENS fraction, was used 
for the fluorescence co-localization studies. Figure 1a shows the photoluminescence (PL) characterization of 
fractions of size-separated ncSi:AB prepared by size-selective precipitation. Fraction A1, the first precipitated 
fraction, is not shown in Fig. 1a as the fraction displays cloudiness that prevents effective photoluminescence 
characterization. Successful size separation was confirmed by measuring the sizes of selected photoluminescent 
fractions using high-angle annular dark field scanning transmission electron microscopy (HAADF-STEM) as 
shown in Fig. 1b. Although not all fractions were characterized by HAADF-STEM, the selected fractions show 
the expected decreasing particle size with increasing fraction number (Supplementary Figure 1 shows size dis-
tribution of individually measured particle sizes). This trend, coupled with the blue shift with increasing fraction 
number (Supplementary Figure 2) which we demonstrated in previous work2, shows the reproducibility of the 
separation method. Representative images of fractions A4 and A10 are shown in Fig. 1c and d to indicate size 
Figure 1. Separation and characterization of silicon nanoparticles. (a) Photoluminescence spectra of 
allylbenzyl-capped silicon nanoparticle (ncSi:AB) fractions show a blue shift in the photoluminescence maxima 
with increasing fraction number (and overall decreasing size); inset: photo of ncSi:AB fractions under UV 
illumination. (b) Plot shows size distribution of selected ncSi:AB fractions. (c) High-angle annular dark field 
scanning transmission electron microscopy (HAADF-STEM) image of fraction 4. (d) HAADF-STEM image of 
fraction 10. Scale bars = 20 nm.
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difference between fractions. It is worth noting that in addition to size differences, two further explanations 
for the difference in PL observed include varying shape of the nanocrystal or a difference in surface coverage. 
Although we were unable to detect noticeable differences in shape or surface coverage from the HAADF-STEM 
data (see Supplementary Figure 3 as examples), we found this characterization sufficient for the first investigation 
of the effect of the size-separation procedure on the cytotoxicity of the nanoparticles.
The next step after separation was to encapsulate the nanoparticles in liposomes. To achieve this, we employed 
the buffered detergent dialysis method. Simply rehydrating a dried film of lipids and nanoparticles did not yield 
any detected encapsulation, as we could not re-solubilize the dried nanoparticle-lipid film during rehydration. 
Using a mixture of Hank’s Buffered Salt Solution (HBSS) with 1% β -octyl glucoside (OCG) to dissolve the dried 
nanoparticle film allowed for the re-solubilization of the nanoparticles before mixing with the already extruded 
liposomes. OCG functioned as a dialyzing agent used to solubilize the nanocrystals. This method resulted in 
larger nanoparticle-lipid complexes for the less toxic fraction A4 and smaller nanoparticle-lipid complexes for the 
more toxic fraction A10 (Supplementary Figure 4). The nanoparticle-liposome structures detected in our experi-
ments showed a lipid monolayer coating of the clusters rather than incorporation into the lipophilic region of the 
already formed liposome. An interesting alternative to this approach which we did not pursue is single particle 
encapsulation into micelles rather than liposomes50,51.
Cytotoxicity was measured for liposomal formulations of all 18 different ncSi:AB fractions and the ENS from 
batches A, B and C by determining the concentration that produces a half-maximal toxicity response (EC-50) on 
cultured HeLa cells (Fig. 2), with lower EC-50 values indicating higher cytotoxicity. Although most screening is 
currently done using a single dose52, we tested the nanoparticle toxicity over 3 dosages in order to account for any 
other effects beyond cytotoxicity that were concentration dependent. HeLa cells were found to be appropriate for 
this first step test due to their wide use in research as a standard initial model cell type. Supplementary Figure 5 
shows toxicity measurements made on three different batches of size-separated ncSi:AB from batches A, B and 
C. Figure 2a is a combined graph of all three batches. We compared the measured EC-50 values for the mono-
disperse ncSi:AB nanoparticles with literature values obtained for toxic silica nanoparticles of about 14 nm from 
Napierska et al.16. The ncSi:AB particles showed a 100-fold lower toxicity than the toxic Stöber silica nanoparticles 
used in the Napierska study and an equivalent level when compared to the non-toxic Stöber silica particles of 
about 335 nm in diameter. The differences in toxicity between the smaller (< 17 nm) silica particles used in the 
Napierska study and ours may arise from a difference in the ligands used and the possibility of the liposomes mit-
igating some of the potential toxic effects. The combined toxicities of the A, B and C ncSi:AB fractions all showed 
at least tenfold lower toxicity than 20 nm SiO2. These values are plotted along with our data to put the numbers 
into perspective, but it should be noted that the data from Napierska et al.16 were carried out on water soluble 
particles in a different cell line.
Although the overall cytotoxicity of ncSi:AB that we measured in HeLa cells is low, there were significant dif-
ferences in the relative cytotoxicity of the different fractions. A one-way ANOVA was performed on the toxicity 
measurements and a significant difference was found between the fractions (p < 0.05). The one-way ANOVA 
only indicated a difference between the EC-50 values and hence a Tukey’s test was performed to compare each of 
the fractions with one another in order to determine which fractions specifically differed from one another. The 
EC-50’s of Fractions 1, 2, 4, 5, 11, 12, 14, 18 and the ensemble (ENS) from batches A, B and C were not found to be 
significantly different from one another or the lipid only control and were labeled the “less toxic”. Fractions 3, 6, 7, 
8, 9, 10, 13, 15, 16, 17 from the same batches A, B, C were each found to be significantly different from the ones in 
the “less toxic group” and hence were labelled “more toxic”. This effect was reproducible between three repetitions 
of the experiment on each batch shown in Supplementary Figure 5. Interestingly, the differential cytotoxicity 
did not follow a monotonic trend with fraction number. Furthermore, the ensemble data showed a low toxicity 
Figure 2. Low, reproducible toxicity of monodisperse ncSi:AB fractions. (a) Graph of EC50 plots showing 
toxicity of 18 fractions, the ENS, the lipid-only control and calculated EC-50 values of toxic and non-toxic 
SiO2 particles from the literature15. The EC-50 values for each fraction were compared between three batches 
using a student t-test to determine the reproducibility of EC-50 values. The error bars represent the standard 
deviation of the triplicate experiments for each batch of nanoparticles (A, B and C). Statistical comparison of the 
EC-50 values of the individual fractions using ANOVA and then the Tukey test on fractions A, B and C showed 
fractions 1, 2, 4, 5, 11, 12, 14, 18 and the ENS to be significantly less toxic (*) than the others (3, 6, 7, 8, 9, 10, 13, 
15, 16, 17). (b) Merged fluorescence and bright field image of a single cell showing localization of nanoparticles 
in the cytoplasm around the nucleus at a lower concentration than the EC-50 value. Scale bar = 5 μ m.
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comparable to the neat lipid controls, which suggests that specific cytotoxic nanoparticles may be enriched in the 
more toxic fractions.
Two possible explanations for the differential cytotoxicity are (1) specific particles may have specific effects 
within the cell1,19,53 and (2) specific particles may be taken up more efficiently by the cells17,54,55. To test these 
hypotheses, we first determined the cellular mechanism of toxicity to see if different fractions induced different 
effects within the cell. We then tested for oxidative stress and DNA damage in the cell. Although no DNA damage 
was detected (Supplementary Figure 6), both the less-toxic and more-toxic fractions showed a significantly higher 
level of oxidative stress than the negative control without ncSi:AB or lipids, the more toxic fraction causing higher 
oxidative stress (Supplementary Figure 6). There was no significant difference in fluorescence from the surface 
between the two tested fractions. The liposomes by themselves did not elicit an oxidative stress response signifi-
cantly different from the negative control. These results indicate that all fractions resulted in some oxidative stress 
on the cell. The generation of reactive oxygen species by the ncSi particles, which could account for the oxidative 
stress, may occur via the Fenton-type reaction undergone by transition elements, which involves the generation 
of hydroxyl radicals from the interaction of exposed silicon surface sites with hydrogen peroxide in the cells56,57. 
Another possible mechanism is through the disruption of mitochondrial membranes resulting in endogenous 
production of reactive oxygen species58,59. The generation of free radicals has been reported to directly oxidize 
DNA, proteins and lipids, thus affecting cell function and integrity6,7,60. Since the mechanism of toxicity appeared 
to be similar for all particles, that is, they all induced oxidative stress, we next tested the hypothesis that the 
more-toxic fractions were taken up more than the less-toxic ones.
First, we selected fractions A4 and A10 as representative of the less toxic and more toxic fractions and exam-
ined their relative uptake by confocal laser scanning microscopy (Fig. 3). Figure 3a–c shows fluorescence images 
of ncSi:AB particles that have been taken up by a single cell, showing that the ncSi:AB particles are localized in the 
cytoplasm and are not present in the nucleus. Figure 3d and e are fluorescence images of the more-toxic fraction 
A10 and the less-toxic fraction A4, respectively. We quantified the amount of ncSi:AB internalized by the cells by 
measuring the average fluorescence intensities of 100 cells for each of fractions A4 and A10. The more-toxic frac-
tion 10 showed significantly higher fluorescence intensity than the less-toxic fraction A4 (Fig. 3f). This suggests 
that the cells internalized the nanoparticles differently; the more-toxic fraction 10 internalized to a higher degree 
than the less-toxic fraction 4.
To further understand the reasons for the differential uptake, we tested the hypothesis that the more-toxic 
fractions were encapsulated more efficiently into the liposomes. We used fluorescence microscopy to quantify 
the encapsulation efficiencies of different fractions of ncSi:AB and compared the result to their cytotoxicity. For 
this part of the experiment a different batch of nanoparticles, batch D, was synthesized and separated. The sep-
aration resulted in 10 monodisperse fractions (Fig. 4) and an ENS fraction this time. Although this varies from 
the number fractions used in the initial toxicity study, it allowed us to confirm a fraction-dependent toxicity of 
the size-separated nanoparticles while also testing the encapsulation efficiency of the different fractions. Figure 4 
Figure 3. Cellular internalization of liposomally encapsulated ncSi:AB particles. (a) High magnification 
fluorescence image showing ncSi:AB particles delivered to a HeLa cell. (b) High magnification of merged 
fluorescence and bright-field images showing ncSi:AB particles delivered to a HeLa cell and localized around the 
nucleus of the cell. Scale bars = 5 μ m. (c) Plot of z-stack fluorescence images taken of (a) showing internalization 
of nanoparticles and the exclusion of the nanoparticles from the nucleus. (d) High magnification confocal 
fluorescence image showing higher fluorescence intensity of ncSi:AB particles localized in HeLa cells for the 
more-toxic fraction A10. (e) High magnification confocal fluorescence image showing lower fluorescence 
intensity of ncSi:AB particles localized in HeLa cells for the less-toxic fraction A4. Scale bars = 20 μm. (f) Plot 
showing the difference in average fluorescence intensity of the internalized nanoparticles in 100 cells for each 
of fractions A4 (less toxic) and A10 (more toxic). *Indicates a significant difference between the two fractions 
using a student t-test, assuming the less-toxic fraction 4 as a control.
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shows fluorescence quantification of the co-localization of nanoparticles and liposomes. Figure 4a shows the 
percentage of empty liposomes as a measure of encapsulation efficiency. Figure 4b further charts the encapsula-
tion of ncSi:AB in liposomes by measuring the co-localization of red (rhodamine-B doped liposomes) and blue 
(ncSi:AB) particles. Figure 4c shows the EC-50 measurement for the new set of fractions used for the fluorescence 
quantification. Figure 4d,g and j show rhodamine-labeled liposomes in the red channel for the lipid control, 
the more-toxic fraction 5 and the less-toxic fraction 7 from batch D. Fractions D5 and D7 were selected as they 
showed a significant difference in the measured EC-50 values (p < 0.05). Figure 4e,h and k show the absence of 
ncSi:AB particles in the lipid-only control, the presence of a high amount of ncSi:AB particles for the more toxic 
fraction D5 and fewer ncSi:AB particles for the less-toxic fraction D7. This suggests that more of the nanoparticles 
are encapsulated into the liposomes of the more-toxic fraction B5 than the less-toxic fraction D7, leading to the 
difference in toxicity to cells. Although it is unclear which fractions in D correspond to which fractions in A, B or 
C, the differences in the number of fractions obtained allowed us to test the reproducibility of our hypothesis of 
fraction-based enrichment of particles suitable for lipid encapsulation and subsequent cellular toxicity.
Supplementary Figure 4 shows the different types and sizes of liposome complexes formed by the less- 
toxic fraction 4 and the more-toxic fraction 10 from batch A. Fraction A4 produced larger (~80 nm diam-
eter) silicon-impregnated liposomes with lower polydispersity measured using dynamic light scattering 
(Supplementary Figure 4) than fraction A10 which produced smaller liposomes (~67 nm diameter) with higher 
polydispersity (Supplementary Figure 4). Interestingly, neither average liposomal size (R2 = 0.0701) nor poly-
dispersity (R2 = 0.2972) showed any correlation with fraction number, suggesting that nanoparticle interaction 
with liposomes and subsequent cellular uptake is unique to specific fractions and not predictable as a trend. 
Specifically, however, while the smaller liposomes of fraction A10 resulted in a larger quantity of liposomal 
nanoparticles delivered to the HeLa cells than did the larger liposomes formed by fraction A4, it is impossible 
to conclude that nanoparticle liposome size is the sole determinant of cellular internalization. This is because 
size-selective precipitation, like some other separation methods, may enrich for other properties like shape and 
ligand density, which could also affect nanoparticle interactions with biomolecules. This is especially true as 
Banerjee et al. have demonstrated that both nanoparticle uptake efficacy and transport are not only dependent on 
size and shape but also are cell-specific61. It is these new nanostructure-function relationships arising only after 
size separation, which make the separation and purification both essential and interesting. Our finding here of 
Figure 4. Fluorescence quantification of ncSi:AB brightness and liposomal encapsulation. (a) Plot of the 
percentage of empty liposomes as an indication of encapsulation efficiency of the fractions. The percentage of 
empty liposomes was obtained by finding the fraction of the liposomes observed in the TRITC channel that 
did not have any nanoparticles (UV channel) at the same location below a chosen threshold. (b) Ratio of blue 
(ncSi:AB) to red (TRITC-labeled liposome) normalized to the quantified (Supplementary Figure 4) brightness 
of the naked particles as a measure of encapsulation of the various fractions. (c) EC-50 toxicity measurements 
of the set of 11 monodisperse ncSi:AB from batch D used in the encapsulation study in A and B. (d–f) are the 
red (TRITC), blue (UV illumination and 580 nm long pass emission for ncSi:AB) and a merged image of both 
channels respectively for the lipid control with no ncSi:AB. G, H, I and J, K, L are the same channels as those 
used in D, E and F, but for fractions D5 and D7, respectively. Scale bar = 30 μ m. Error bars represent standard 
deviations from triplicate samples. Comparison of the toxicity was done using a one-way ANOVA and a 
subsequent post hoc Tukey’s test as previously used in Fig. 2. Fractions D5 and D7 were chosen for comparison 
because they differed significantly from each other.
www.nature.com/scientificreports/
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fraction-based differences in liposomal interaction of the silicon nanocrystals has implications in the liposomal 
delivery of nanomaterials, as well as in the understanding of size-dependent biological activity.
For instance, liposomes are often used as model cell membranes, and the ability of the more-toxic fractions to 
disperse better in liposomes suggests that they may also disperse better in biological membranes. Since disruption 
of mitochondrial membranes is one source  which leads to oxidative stress, lipophilic nanoparticles may exhibit 
fraction-dependent effects within the cell due to the enrichment of particles with specific properties. Although 
the size-separated fractions are significantly more monodisperse than the ensemble, they too are a combination of 
particles of various sizes. Additional separation and characterization of the fractions may further enrich the more 
cytotoxic fractions and provide more insight into the mechanisms of nanomaterial interactions with biological 
systems. Further studies are therefore planned to fully characterize the nanoparticles in order to expand on and 
fully determine the rules that govern biological interactions of the monodisperse nanoparticles.
Conclusion
Overall, the low toxicity shown by the silicon nanoparticles in this study represents a promising step forward in 
the drive to produce non-toxic nanomaterials. The increase in surface area of nanoparticles with decreasing size, 
which has accounted for the trend of higher toxicity of smaller sized nanoparticles4, does not seem to apply here. 
We further detected that within the range of nontoxicity of the silicon nanoparticles, there was a reproducible 
fraction dependence in the effects they had on the HeLa cells, which may depend on factors including but not 
limited to nanoparticle size. This fraction-dependent effect appears to be related to the specific interaction with 
liposomes that can affect their encapsulation efficiency and hence the efficiency of internalization should they be 
used in the hydrophobic form. This work demonstrates the value of further purification and screening of synthe-
sized nanoparticles and opens the possibility of screening lipophilic nanomaterial drugs and libraries62–64.
Materials and Methods
Nanoparticle synthesis. The ncSi:AB were synthesized according to the previously reported sol-gel prepa-
ration with slight modifications65. Briefly, 10 mL of HSiCl3 (13.4 g, 99 mmol) was mixed with distilled water 
(40 mL, 2.22 mol) in a dry ice/acetone bath (− 78 °C), forming a white solid (HSiO1.5)n sol-gel glass. After wash-
ing with distilled water, filtering and drying it under vacuum, the solid (HSiO1.5)n was thermally processed in 
a slightly reducing atmosphere (5% H2/95% Ar) to a peak processing temperature of 1100 °C at 18 °C/min and 
maintained there for 1 hour. The resulting light brown solid ncSi/SiO2 composite was mechanically ground in 
a mortar and pestle. Then 1.20 g of composite was stirred with 20 ml of ethanol and 40 ml of 49% HF (aq) in a 
polypropylene beaker for 2.5 h to etch the SiO2 matrix, liberate the ncSi, and gradually decrease particle size. The 
hydride-capped ncSi were extracted from the aqueous etching mixture using 35 ml of allylbenzene. Dissolved 
gases were removed by putting the flask under vacuum for about 20 min, then the solution was heated in an oil 
bath at 155 °C under a nitrogen atmosphere and left to stir for 17 hours. The resulting translucent orange solution 
was cooled and centrifuged for 20 min at 6461 rpm. The transparent orange supernatant was collected, and the 
precipitate was discarded. The allylbenzene was removed by vacuum distillation, and the solid was heated to 
150 °C for 4 hours to remove any excess traces of the ligand. The polydisperse allylbenzyl-capped silicon nanocr-
sytal (ncSi:AB) solid was re-suspended in 10 ml of anhydrous toluene to give a clear orange solution.
Nanoparticle separation and photoluminescence measurements. Size-selective precipitation was 
performed by repeatedly adding methanol to the ncSi:AB dispersion, followed by sonication for 20 s, centrifuga-
tion for 10 min at 6461 rpm, then decanting the clear solution from the solid precipitate. Solid ncSi:AB fractions 
were transferred directly into a glovebox and dispersed in 0.75 ml of toluene. This process was repeated with the 
supernatant until all fractions had been collected. UV-vis absorption spectra of the ensemble and fractions of 
ncSi:AB were obtained on a Perkin Elmer Lambda 900 UV/VIS/NIR spectrometer. Photoluminescence spec-
tra of the ncSi:AB ensemble and fractions were obtained by exciting toluene solutions in an integrating sphere 
(Gigahertz Optik, custom made) with light from a 365 nm LED (Thorlabs M365L2), using a 1 mm diameter 
optical fibre (Ocean Optics) for collection and an Ocean Optics Maya 2000 spectrometer for detection. Three sets 
of mass-normalized samples were isolated by transferring specific amounts of each ncSi:AB dispersion based on 
the absorbance at 450 nm (average recorded between 449–451 nm) of each fraction to a new clean vial. All sam-
ples were left to dry for 3 days in a vacuum desiccator, then transferred to a glove box to be sealed under an inert 
atmosphere until used for the toxicity measurements.
Electron microscopy. High-angle annular dark field scanning transmission electron microscopy 
(HAADF-STEM) was performed using an image-corrected FEI Titan 80–300 electron microscope. The micro-
scope was operated at 300 kV, providing a nominal resolution of 0.14 nm. The ncSi:AB samples were drop-cast 
from toluene onto holey carbon-coated copper grids, which were further coated with 2 nm carbon film 
(Quantifoil). The HAADF-STEM images were processed by the non-linear anisotropic diffusion algorithm imple-
mented in IMOD4 V4.1.4 for noise reduction prior to further analysis. Particle size measurement was done in 
imageJ by first calibrating each image using the scale from the original TEM image. A freehand ROI was drawn 
around a selected group of tightly packed particles to determine the overall area. This area was then divided by 
the number of particles within the ROI (Supplementary Figure 7). This process was repeated for multiple images 
for each fraction number and a standard deviation calculated. Particles were chosen for measurement based on 
experience to determine clarity of particle. For single particle distribution, each visible particle was measured 
by drawing lines which were roughly perpendicular to each other from one edge of a particle to the opposite 
edge. The average of the perpendicular diameters was then calculated and taken as the individual particle size 
(Supplementary Figure 7). A histogram was then made of the particle size distribution.
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Liposome formulation. 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-
3-phospho-L-serine (sodium salt) (DOPS) and cholesterol in chloroform were mixed in a glass vial in the ratio 
5.5:3.5:1. Liposomal formulations of the different fractions were made by first preparing the liposomes using 
the hydration method, sonicating the liposomes, and then extruding them through a 0.1 μ m membrane filter. 
A selected nanoparticle fraction dissolved in chloroform was aliquoted into a class vial and dried in a vacuum 
overnight. The dried film was then re-solubilized by adding a mixture of HBSS (without calcium or magne-
sium) and β -octyl glucoside, sonicating at 60 °C for 10 minutes and filtering 4 times through a 100 K Amicon® 
Ultra centrifugal filter purchased from MilliporeTM. The extruded liposomes were then added to the nanoparticle 
fractions and the mixture sonicated. This allowed for the lipids to coat aggregates of nanoparticles, as shown in 
Supplementary Figure 4B for the non-toxic fraction 4 and Supplementary Figure 4C for the more-toxic fraction 
10. This method, a slight variation on existing encapsulation methods29,30, was employed because standard encap-
sulation methods involving the mixing of the lipids and hydrophobic nanoparticles in organic solvent before 
drying and reconstitution in buffer failed to yield any delivery into the cell.
Cell toxicity assay. Hela cells were purchased directly from the American Type Culture Collection. Cells 
were plated in a tissue culture plate 24 hours prior to the experiment so that they were at a confluence of 70% at 
the time of incubation with the liposomes. To determine uptake, the cells were imaged 2 hr after incubation with 
liposomal nanoparticles. For toxicity, the cells were incubated with the liposomal nanoparticles for 48 hours and 
then stained with DAPI for cell viability counting.
Statistics. The dose response experiments for each fraction were done in triplicate. To determine whether 
there was a difference in the toxicity measurements of the different fractions, a one-way ANOVA was performed 
on all the fractions. If a p value of < 0.05 was obtained, then a Tukey’s test was conducted to compare the indi-
vidual EC-50 values to see which ones specifically differed from one another. The group of fractions with lower 
EC-50 values was labeled “more toxic” while the group with the higher EC-50 values was labelled “less toxic”. A 
fraction from each group was then chosen for use in the “more toxic” versus “less toxic” comparisons.
Determination of mechanism of toxicity. In order to observe the nucleus for morphological changes, 
treated cells were stained with DAPI and compared to control cells with liposomes only and with media only. 
Cellular hypoxia and oxidative stress levels were determined using the hypoxia/oxidative stress kit from Sigma 
Aldrich.
Differential Scanning Calorimetry (DSC) measurements. The DSC measurements were performed 
using the (TA) Nano-DSC from Thermal Analysis with the autosampler. The scan rate of 1 C°/min was set with 
a target temperature range from T = 10 C° to 70 °C. Baseline scans were acquired by scanning the buffer solvent. 
Ethanol, the detergent Contrad 50, and water were used in the cleaning process. The extra water scan was exe-
cuted before and after each sample run to make sure that an identical thermogram was obtained. Sample concen-
tration of 1 mg/mL at a volume of 1 mL was used for all measurements.
Dynamic Light Scattering measurements. The scattered light intensity was measured using a Malvern 
Zetasizer Nano ZS (Malvern, Herrenberg, Germany) equipped with a 633-nm He-Ne laser and operating at an 
angle of 173°. The Dispersion Technology Software, from Malvern, was used to collect and analyze the data. The 
measurements were made at a controlled temperature of 25 °C, on 500 μ l of each sample measured in single-use 
polystyrene cuvettes (Fisher Emergo, Landsmeer, The Netherlands) with a pathlength of 10 mm. The intensity 
size distribution, the Z-average diameter (Z-ave) and the polydispersity index (PdI) were obtained from the auto-
correlation function. The default upper threshold of 0.01, lower threshold of 0.05, and the default filter factor of 
50% were used.
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